Antares Therapeutics
Focus: Antares Therapeutics is a public biotechnology company focused on small molecule therapies across endocrinology, immunology, oncology, neurology, and gastroenterology. The company is heavily concentrated in migraine and hypogonadism markets.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Antares Therapeutics?
AI assessmentA stagnant-to-declining specialty pharma play with one revenue driver and minimal pipeline momentum—suitable only for those seeking stability in a mature migraine market, not growth or innovation.
Why Work Here
- Two marketed products with peak lifecycle status (ZEMBRACE SYMTOUCH and XYOSTED) providing established revenue base and market presence
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
1 imminent
SUMAVEL DOSEPRO
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$75K Part DStable
Peak9.7yr
Help build intelligence for Antares Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.